Case Report
Varying Presentations of Multisystem Inflammatory Syndrome Temporarily Associated with COVID-19
Table 2
Definition of MIS-C by the WHO [
7].
| (1) Children and adolescents 0–19 years of age with fever >3 days | (2) AND two of the following: | (i) Rash or bilateral nonpurulent conjunctivitis or mucocutaneous inflammation signs (oral, hands, or feet) | (ii) Hypotension or shock | (iii) Features of myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities (including ECHO findings or elevated troponin/NT-proBNP) | (iv) Evidence of coagulopathy (by PT, PTT, and elevated D-dimers) | (v) Acute gastrointestinal problems (diarrhoea, vomiting, or abdominal pain) | (3) AND elevated markers of inflammation such as ESR, C-reactive protein, or procalcitonin | (4) AND no other obvious microbial cause of inflammation, including bacterial sepsis and staphylococcal or streptococcal shock syndromes | (5) AND evidence of COVID-19 (RT-PCR, antigen test, or serology positive) or likely contact with patients with COVID-19 |
|
|